首页 | 本学科首页   官方微博 | 高级检索  
检索        

冠心病患者血浆纤维蛋白原与hs—CRP及血脂检测的临床意义
引用本文:余冬梅,周明刚,唐川苏.冠心病患者血浆纤维蛋白原与hs—CRP及血脂检测的临床意义[J].中国航天工业医药,2013(9):30-32.
作者姓名:余冬梅  周明刚  唐川苏
作者单位:四川省遂宁市中心医院心内科,629000
摘    要:目的探讨血浆纤维蛋白原(FIB)与超敏C反应蛋白(hs—CRP)、血脂在冠心病诊疗中的价值。方法回顾性分析我院收治的98例冠心病患者与60例正常人群的临床资料,比较两组中血浆FIB、hs—CRP以及血脂水平的差异.以及3者与冠心病严重程度的关系。结果冠心病组中LDL—C水平均高于正常组,差异有统计学意义(P〈0.05)。冠心病组的急性心肌梗死(AMI)与不稳定性心绞痛(UAP)的FIB、hs—CRP水平均高于正常组,差异有统计学意义(P〈O.05),稳定性心绞痛(SAP)与正常组差异无统计学意义(P〉O.05)。与正常组相比较,血管病变支数越多,FIB、hs—CRP、LDL—C的水平越高,差异有统计学意义(P〈0.05)。结论通过检测FIB、hs—CRP能够判断疾病严重程度.对诊断及预后判断有重要价值。

关 键 词:冠心病  血浆纤维蛋白原  超敏C反应蛋白  血脂

Clinical significance of detection of plasma fibrinogen and high sensitivity C-reactive protein in coronary heart disease
Authors:Yu Dongmei  Zhou Minggang  Tang Chuansu
Institution:. Suining Central Hospital,Suining 629000
Abstract:Objective To investigate the value of detection of plasma fibrinogen (FIB) and high sensitivity C-reactive protein (hs-CRP) in coronary heart disease. Methods Detected the levels of the FIB and hs-CRP of 98 cases with coronary heart disease and 60 cases of normal physical examination in our hospital, and analyzed the relationship among the FIB, hs- CRP expressions and the seriousness of coronary heart disease. Results The LDL-C level of coronary heart disease group was significantly higher than that of the control group (P〈0.05). The FIB and hs-CRP levels of acute myocardial infarction (AMI) and unstable angina pectoris (UAP) in CHD group were significantly higher than that of the control group (P〈0.05) ; these fig- ures were no difference in unstable angina(SAP) compared to the control group(P〉0.05); compared to the control group, FIB and higher hs-CRP levels were significantly higher in multi-vessel disease (P〈0.05). Conclusion The detection of FIB and hs-CRP levels can judge the seriousness of the disease, and is valuable for diagnosis and prognosis.
Keywords:Coronary heart disease Plasma fibrinogen High sensitivity C-reactive protein Blood liquid
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号